Strong dose-response on Immunoglobulin markers during a Phase II Allergen Immunotherapy study with subcutaneously administered Tyrosine adsorbed modified grass allergen + MPL

Strong dose-response on Immunoglobulin markers during a Phase II Allergen Immunotherapy study with subcutaneously administered Tyrosine adsorbed modified grass allergen + MPL

Zielen S., Aberer W., Lassmann S., Wade A., Kluehr K., Raab J., Lee D., Ballard R., Jones C., Gunawardena K., Kramer M.K., Skinner M.A., De Kam P.J.
EAACI, Lisbon, 2019